成都市成人健康体检脂肪肝患病率和危险因素研究

目的探讨成都市成人健康体检脂肪肝患病率及危险因素分析，并为脂肪肝防治提供可靠依据。方法收集2007年6月-2008年2月成都市成人健康体检资料共计12152例，分别统计年龄、性别、饮酒量、体重指数、空腹血糖、血清总胆固醇、三酰甘油、B超结果。结果参加体检人数共计12152例，其中男7520例，女4632例，年龄18-86岁，平均47.8岁。成都市成人健康体检脂肪肝患病率14.71％，其中酒精性脂肪肝患病率为2.46％，非酒精性脂肪肝患病率为12.25％；男性和女性脂肪肝患病率分别为19.48％和6.97％。在所有脂肪肝患者中超重和肥胖分别占56.54％和25.06％，总胆固醇和三酰甘油增高者分别占23.83％和51.01％，过量饮酒者占16.72％，空腹血糖增高占12.36％。结论成都市成人健康体检脂肪肝患病率14.71％，男性明显高于女性，分别为19.48％和6.97％；脂肪肝主要危险因素分别为超重或肥胖、高脂血症、饮酒和糖代谢异常。

A epidemiological survey on fatty liver and its risk factors among adult population of health examination in chengdu.

Objective To investigate the prevalence of fatty liver and major risk factors among adult population of health examination in Chengdu, and to provide information for control and prevention of the disease. Methods The data including year old, sex, alcohol intake, body mass index（MBI）, fasting blood glucose, total cholesterol, triglyceride, results of B-ultrasound were recorded in detail among 12152 people of health examination in Chengdu from June 2007 to February 2008. Results A total of 12152 residents took part in the health examination. Of the 12152 residents ,7520 were males and 4632 were females. The mean age of the participants was 47.8 years and ranged from 18-86 years. The prevalence of fatty liver among adult population of health examination was 14.71%, among which the incidence of alcohol fatty liver and NAFLD were 2.46% and 12.25% respec-tively. The prevalence of fatty liver was 19.48% in male and 6. 97% in female. Of all fatty liver residents,56.54% had over-weight,25.06% had obesity, increases of total cholesterol and triglyceride were 23.83% and 51.01% respectively, overdose of alcohol intake was 16.72%, and fasting hyperglycemia was 12.36%. Conclusion The prevalence of fatty liver among adult population of health examination in Chengdu was 14.71%. The incidence of males were significandy higher than females, 19.48% and 6.97% respectively. The major risk factors of fatty liver were overweight or obesity,hyperlipemia,overdose of alco- hol intake and fasting hyperglycemia.